Spontaneous coronary artery dissection: a disease-specific, social networking community-initiated study.
Marysia S Tweet, Rajiv Gulati, Lee A Aase...
https://pubmed.ncbi.nlm.nih.gov/21878595Actively Recruiting
Led by Mayo Clinic · Updated on 2026-04-15
2000
Participants Needed
1
Research Sites
104 weeks
Total Duration
Researchers are investigating the genetic causes of spontaneous coronary artery dissection (SCAD), a condition involving tears in the heart's blood vessels. This study aims to identify inherited and new mutations that may cause or increase the risk of SCAD. The research includes adults diagnosed with SCAD, as well as their biological parents and relatives with related artery conditions like fibromuscular dysplasia and arterial aneurysm. The study involves collecting blood or saliva samples to create a biobank of genomic DNA and plasma from people with SCAD. Confirmation of SCAD diagnosis through coronary angiography review is required before enrollment. Both retrospective and prospective participants will be included to help identify genetic mutations responsible for SCAD and common genetic variants that may increase susceptibility. Participants will provide informed consent and complete a questionnaire. Researchers will review participants' coronary angiography images and collect genetic samples for analysis. The main outcome measure is identifying one or more gene mutations linked to SCAD by the end of the study. The trial is observational, with no treatment interventions, and participation involves genetic testing and data collection procedures.
CONDITIONS
Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to several months depending on enrollment timing
Participants provide blood or saliva samples for genetic analysis and complete a questionnaire. Biological relatives may also provide samples depending on their eligibility.
1 to 2 visits depending on family member involvement
Duration - Up to study completion in December 2030
Participants are observed over time to support genetic research and biomarker development related to spontaneous coronary artery dissection (SCAD).
Visits as needed for sample collection and assessments
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
J
Jake Nemgar
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Marysia S Tweet, Rajiv Gulati, Lee A Aase...
https://pubmed.ncbi.nlm.nih.gov/21878595Sharonne N Hayes, Esther S H Kim, Jacqueline Saw...
https://pubmed.ncbi.nlm.nih.gov/29472380Stanislav Henkin, Sara M Negrotto, Marysia S Tweet...
https://pubmed.ncbi.nlm.nih.gov/26864667Kashish Goel, Marysia Tweet, Timothy M Olson...
https://pubmed.ncbi.nlm.nih.gov/25798899David Adlam, Timothy M Olson, Nicolas Combaret...
https://pubmed.ncbi.nlm.nih.gov/30621952Tamiel N Turley, Jeanne L Theis, Rhianna S Sundsbak...
https://pubmed.ncbi.nlm.nih.gov/30888838Tamiel N Turley, Megan M O'Byrne, Matthew L Kosel...
https://pubmed.ncbi.nlm.nih.gov/32374345David Adlam, Takiy-Eddine Berrandou, Adrien Georges...
https://pubmed.ncbi.nlm.nih.gov/37248441Tamiel N Turley, Matthew L Kosel, William R Bamlet...
https://pubmed.ncbi.nlm.nih.gov/34384238Susan N Kok, Sharonne N Hayes, F Michael Cutrer...
https://pubmed.ncbi.nlm.nih.gov/30561271